Synthetic hormones related to the natural hormone GnRH, or gonadotropin releasing hormone.

A GnRH-analog that briefly stimulates the pituitary gland to release follicle stimulating hormone (FSH) and luteinising hormone (LH), but then within a few days reduces these hormones to low levels (you could say that the pituitary has had a clamp put on it), stopping these hormones from competing with administered hormones -- and, particularly in women, suppressing the LH surge that otherwise can spoil the timing of egg retrieval in an assisted conception program such as IVF or GIFT. Examples include: leuprorelin(Lucrin, made by Abbott, used in Australia and Europe) or leuprolide (Lupron, made by Abbott in the US); nafarelin (Synarel, by Syntex); goserelin (Zoladex, by ICI); triptorelin (Decapeptyl, by Ipsen Biotech and used in Europe) and buserelin (Suprefact, by Hoechst, used in Europe).

A GnRH-analog that (unlike GnRH-agonists) immediately stops the pituitary gland from releasing the gonadotropins follicle stimulating hormone (FSH) and luteinising hormone (LH). Can substitute for GnRH-agonists for many gynecological purposes (particularly to suppress the LH-surge in assisted conception), although its use with pure FSH preparations (such as Fertinex, Gonal-F, Metrodin HP or Puregon) can lead to poor egg quality unless the dosage is carefully controlled or some luteinising hormone is added to the stimulation regimen.

Measurement of luteinising hormone in blood serum. Used in monitoring to judge the occurrence of the LH surge, if GnRH-analogs have not been employed. The result should be available within 4 hours of the test for this purpose.